ArticleJournal for immunotherapy of cancer2019

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.

Mirjam Fässler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.